MedPath

MacuCLEAR, Inc.

MacuCLEAR, Inc. logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Subsidiary
Established
2006-01-01
Employees
11
Market Cap
-
Website
http://www.macuclear.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration

Phase 2
Conditions
Non-Exudative Age Related Macular Degeneration
Interventions
Drug: MC-1101 Vehicle
First Posted Date
2014-04-30
Last Posted Date
2014-04-30
Lead Sponsor
MacuCLEAR, Inc.
Target Recruit Count
60
Registration Number
NCT02127463
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Rocky Mountain Retina Consultants, Murray, Utah, United States

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

Phase 1
Completed
Conditions
Nonexudative Age-related Macular Degeneration
Interventions
Drug: MC-1101, Placebo
First Posted Date
2013-08-14
Last Posted Date
2014-04-21
Lead Sponsor
MacuCLEAR, Inc.
Target Recruit Count
20
Registration Number
NCT01922128
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sall Eye Center, Artesia, California, United States

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

Phase 2
Terminated
Conditions
Nonexudative Age Related Macular Degeneration
Interventions
Drug: MC-1101 Vehicle
First Posted Date
2012-05-18
Last Posted Date
2014-04-28
Lead Sponsor
MacuCLEAR, Inc.
Target Recruit Count
22
Registration Number
NCT01601483
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Michigan, Ann Arbor, Michigan, United States

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Phase 1
Completed
Conditions
Age-Related Macular Degeneration
Interventions
Drug: Vehicle
First Posted Date
2009-11-13
Last Posted Date
2009-11-13
Lead Sponsor
MacuCLEAR, Inc.
Target Recruit Count
31
Registration Number
NCT01013376
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Andover Eye Associates, Andover, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.